Vasomedical, Inc. - EECP® Therapy

What's New

New Indian Health Magazine Features EECP® Therapy In Its Cover Story

Vasomedical Applauds the International EECP® Therapist Association Call for International EECP® Therapy Week in Recognition of American Heart Month

Chapter Dedicated to EECP® Therapy in New Textbook on Coronary Artery Disease

Vasomedical Recorded Record Net Income of $2.47 Million for the Second Quarter of Fiscal 2012

More >>

Overview

Corporate Profile

Vasomedical Inc. provides superior medical products and services that address unmet clinical needs in the management of patients with heart disease.

Recent News

2012
Jan
1/17		Vasomedical Recorded Record Net Income of $2.47 Million for the Second Quarter of Fiscal 2012
1/12		Vasomedical and EECP® Therapy Presented on at the OneMedForum2012 in San Francisco

2011
Oct
10/17		Vasomedical Reports Financial Results for the Quarter Ended August 31, 2011
10/5		Notice Of Annual Meeting Of Stockholders

Sep
9/21		Vasomedical Announces Corporate Restructure and Appointment of New Chief Financial Officer
9/8		Vasomedical Completes Acquisition of Life Enhancement Technology and Biox Instruments

Aug
8/30		Vasomedical Reports Financial Results for the Year Ended May, 31, 2011
8/23		Vasomedical Announces Agreement to Acquire Two China-Based Companies
8/3		Dr. Jun Ma of Vasomedical Interviewed on OneMedRadio A Frank Discussion of the Company’s Growth Strategy

Jul
7/6		Vasomedical Receives FDA 510(k) Clearance on Two Additional BIOX™ Monitors

Jun
6/29		Vasomedical Receives FDA 510(k) Clearance on Two New Devices

Apr
4/15		Vasomedical Reports Financial Results for the Quarter Ended February, 28, 2011

Mar
3/2		Vasomedical Positioned to Seek Increased Reimbursement Coverage for EECP® Therapy

Jan
1/18		Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010

1/10		Vasomedical Announces Launch of Its Online Company Store

2010
Oct
10/21		Latest Study Provides Evidence Confirming the Mechanism of Action of Vasomedical’s EECP Therapy in Treating Cardiovascular Disease

July
7/29		VasoHealthcare Holds Launch Summit 2010 In Greensboro, NC
7/20		Vasomedical Releases iPhone Application for EECP^® Therapy

June
6/29		Vasomedical Announces Reorganization of Its Board of Directors

May
5/24		Vaso Healthcare, a Subsidiary of Vasomedical, Inc. Signs Exclusive Sales Representative Agreement with GE Healthcare

Apr
4/9		Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System

Upcoming Events

AHA - American Heart Association
Scientific Sessions 2011
November 13 – 15, 2011
Orlando, Florida USA
Booth # 1832

ACC - American College of Cardiology
61st Annual Scientific Session and Expo
March 24 – 27, 2012
Chicago, Illinois USA
Booth # 14097